C
NVO

Covestor’s Novo Nordisk NVO Stock Holding History

Covestor’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,077
Closed -$55K – 2617
2025
Q4 		$55K Sell
1,077
-123
-10% -$6.29K 0.03% 874
2025
Q3 		$67K Buy
1,200
+404
+51% +$23.6K 0.04% 774
2025
Q2 		$55K Sell
796
-746
-48% -$50.7K 0.03% 856
2025
Q1 		$107K Sell
1,542
-365
-19% -$30.1K 0.07% 443
2024
Q4 		$164K Sell
1,907
-198
-9% -$21.4K 0.1% 258
2024
Q3 		$251K Buy
2,105
+28
+1% +$3.73K 0.16% 99
2024
Q2 		$296K Sell
2,077
-25
-1% -$3.31K 0.19% 64
2024
Q1 		$270K Buy
2,102
+26
+1% +$3.1K 0.17% 67
2023
Q4 		$215K Buy
2,076
+708
+52% +$70K 0.15% 115
2023
Q3 		$124K Buy
1,368
+2
+0.1% +$176 0.09% 304
2023
Q2 		$111K Buy
+1,366
New +$112K 0.08% 375

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Covestor's NVO Position: Q1 2026 in Review

Covestor sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 1,077 shares — an estimated $55K sold.

Covestor first reported a position in NVO in Q2 2023 and held it in 11 quarters. The position peaked at $296K in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Covestor reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Covestor sold 1,077 Novo Nordisk shares in Q1 2026, an estimated $55K.
  • Covestor first reported a position in Novo Nordisk in Q2 2023 and held it in 11 quarters.
  • Covestor's Novo Nordisk position peaked at $296K in Q2 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.